Current Perspectives on Drug Therapies for Anorexia Nervosa and Bulimia Nervosa

March 1991. Contact Available from ADIS International. Suite B-30, Oxford Court Business Center, 582 Middletown Boulevard, Langhorne, PA 19047. (215) 752-4500. ISSN 0012-6667. Summary This article presents current perspectives on drug therapies for anorexia nervosa and bulimia nervosa. Topics include diagnostic considerations, drug treatment for anorexia nervosa, and drug treatment for bulimia nervosa. The authors maintain that there is little if any role for...

Identifying a Neurobiological Basis for Drug Therapy in TMDs

Journal of American Dental Association. 127 5 581-593. May 1996. Summary Emerging results from clinical and basic research indicate that persistent pain results in changes in the central nervous system. This article reviews data that support the use of tricyclic antidepressants for neurogenic or atypical pain, and benzodiazepines for musculoskeletal pain. Other topics covered include the pathophysiology of persistent pain and the pharmacological management of temporomandibular...

Donepezil Improves Symptoms of Delirium in Dementia Implications for Future Research

Source Journal of Geriatric Psychiatry and Neurology. 11 159-161. Fall 1998. Summary This journal article discusses a case study of delirium, complicated by preexisting dementia, that was resolved rapidly following initiation of the cholinesterase inhibitor donepezil. The authors suggest that cholinergic dysfunction may have played a role in the etiology of the patient's delirium. Delirium is a common complication of dementia that may produce agitation, which may be refractory to conventional...